Ask Your Clinician if a GLP-1 May Be Right for You GLP-1 medications have changed the landscape of care for people navigating type 2 diabetes and weight loss
In fact, yeast infections are among the most frequently reported side effects of this class of medications, along with urinary tract infections, increased urination, nausea, and constipation
Moreover, a total of 267 DEGs from GSH- and Glu-treated groups existed in wounding treatment, among which 126 genes were co-regulated by GSH, Glu and wounding, 81 genes were only regulated by GSH and wounding, and 60 genes were only regulated by Glu and wounding (Fig
Several studies have found a link between ASD and ferroptosis [239]
Policy Endocrinologist Anira Iqbal, MD, explains why GLP-1s work best the longer you take them
Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026